Therapeutic vaccine targeting dual immune checkpoints induces potent multifunctional CD8+ T cell anti-tumor immunity
The Ad vaccine targeting dual immune checkpoints B7H1 and B7H3 exerts a potent therapeutic effect for renal carcinoma and holds promise for solid tumor treatment.
Authors
- Zheng Lu
- Fei Zhu (ORCID: https://orcid.org/0000-0003-1311-2434)
- Junnian Zheng (ORCID: https://orcid.org/0000-0003-0208-6410)
- Jiage Ding (ORCID: https://orcid.org/0000-0001-6047-6228)
- Dafei Chai (ORCID: https://orcid.org/0000-0002-8028-2954)
- Gang Wang (ORCID: https://orcid.org/0000-0001-6020-7263)
- Yanyan Zheng (ORCID: https://orcid.org/0000-0001-7742-7684)
- Bowen Lu (ORCID: https://orcid.org/0000-0003-3361-8168)
- Lin Fang
- Guangya Zhao
- Yingxiang Shao
Institutions
- Xuzhou Medical College (CN)
- Xuzhou Central Hospital (CN)
Publication Details
- Journal
- International Immunopharmacology
- Published
- 2024-08-31
- DOI
- https://doi.org/10.1016/j.intimp.2024.113004
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.28